Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7647)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2019 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng SZ, Sun P, Wang JP, Liu Y, Gong W, Liu J. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. World J Gastroenterol 2019; 25(22): 2752-2762 [PMID: 31235998 DOI: 10.3748/wjg.v25.i22.2752] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i22/2752.htm |
| Number | Citing Articles |
| 1 |
Xin-Yan Lu, Hongxu Jin. MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1486783
|
| 2 |
Yu Wang, Yingying Wang, Zhiyuan Qin, Sheng Cai, Lushan Yu, Haihong Hu, Su Zeng. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(3): 291 doi: 10.1080/17425255.2021.1887139
|
| 3 |
Ya-ruo Lei, Xian-lu He, Jun Li, Chun-fen Mo. Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects. Frontiers in Bioscience-Landmark 2024; 29(2) doi: 10.31083/j.fbl2902052
|
| 4 |
Soudeh Ghafouri-Fard, Kasra Honarmand Tamizkar, Bashdar Mahmud Hussen, Mohammad Taheri. MicroRNA signature in liver cancer. Pathology - Research and Practice 2021; 219: 153369 doi: 10.1016/j.prp.2021.153369
|
| 5 |
Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, Dana K. Sabir, Mohammad Taheri, Soudeh Ghafouri-Fard. MicroRNA: A signature for cancer progression. Biomedicine & Pharmacotherapy 2021; 138: 111528 doi: 10.1016/j.biopha.2021.111528
|
| 6 |
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nature Reviews Cancer 2023; 23(11): 762 doi: 10.1038/s41568-023-00612-3
|
| 7 |
Rong Luo, Han Jin, Lan Li, Yu-Xiang Hu, Fan Xiao. Long Noncoding RNA MEG3 Inhibits Apoptosis of Retinal Pigment Epithelium Cells Induced by High Glucose via the miR-93/Nrf2 Axis. The American Journal of Pathology 2020; 190(9): 1813 doi: 10.1016/j.ajpath.2020.05.008
|
| 8 |
Yeliz Yılmaz, Tuğçe Batur, Peyda Korhan, Mehmet Öztürk, Neşe Atabey. Liver Cancer in the Middle East. 2021; : 333 doi: 10.1007/978-3-030-78737-0_21
|
| 9 |
Mohammad Taheri, Bashdar Mahmud Hussen, Farhad Tondro Anamag, Hamed Shoorei, Marcel E. Dinger, Soudeh Ghafouri-Fard. The role of miRNAs and lncRNAs in conferring resistance to doxorubicin. Journal of Drug Targeting 2022; 30(1): 1 doi: 10.1080/1061186X.2021.1909052
|
| 10 |
Yuzhen Ge, Rui Zhao, Bo Li, Benli Xiao, Lei Zhou, Shi Zuo. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37. Experimental Cell Research 2022; 421(2): 113377 doi: 10.1016/j.yexcr.2022.113377
|
| 11 |
Shireen S. Mahmoud, Samia Hussein, Hayam Rashed, Eman M. A. Abdelghany, Alaa I. Ali. Anticancer Effects of Tacrolimus on Induced Hepatocellular Carcinoma
in Mice. Current Molecular Pharmacology 2022; 15(2): 434 doi: 10.2174/1874467214666210531164546
|
| 12 |
Yichen Tian, Yongrong Lei, Yani Wang, Jiejuan Lai, Jianhua Wang, Feng Xia. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review). International Journal of Oncology 2023; 63(5) doi: 10.3892/ijo.2023.5567
|
| 13 |
Chang Xu, Xiaocheng Cao, XiaoZheng Cao, Lihua Liu, Yebei Qiu, Xiang Li, Lingli Zhou, Yingxia Ning, Kaiqun Ren, Jianguo Cao. Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(14): 1654 doi: 10.2174/1871520620666200424123139
|
| 14 |
Behnaz Lahooti, Sagun Poudel, Constantinos M. Mikelis, George Mattheolabakis. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.705634
|
| 15 |
Soudeh Ghafouri-Fard, Hamed Shoorei, Mahdi Mohaqiq, Jamal Majidpoor, Mohammad Amin Moosavi, Mohammad Taheri. Exploring the role of non-coding RNAs in autophagy. Autophagy 2022; 18(5): 949 doi: 10.1080/15548627.2021.1883881
|
| 16 |
Xiaopeng Xu, Minghui Li, Wenjia Xu, Min Wang, Yan Wu, Liying Cheng, Jinyang Li, Yang Qin, Sha Liu, Gangqiang Yang, Kaoxiang Sun, Peng Zhang. A Combination of Biocatalysis and Fenton-Like Reaction Induced OH• Burst for Cascade Amplification of Cancer Chemodynamic Therapy. Molecular Pharmaceutics 2024; 21(7): 3434 doi: 10.1021/acs.molpharmaceut.4c00143
|
| 17 |
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farhad Adhami Moghadam, Maliheh Entezari, Zeinab Khazaei Koohpar, Elahe Sadat Hejazi, Shamin Rezaei, Amirabbas kakavand, Maryam Aboutalebi, Mohammad Arad Zandieh, Romina Rajabi, Shokooh Salimimoghadam, Afshin Taheriazam, Mehrdad Hashemi, Saeed Samarghandian. miRNAs as short non-coding RNAs in regulating doxorubicin resistance. Journal of Cell Communication and Signaling 2023; 17(4): 1181 doi: 10.1007/s12079-023-00789-0
|
| 18 |
Fanbo Jing, Xiao Li, Hui Jiang, Jialin Sun, Qie Guo. Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow. Biomedicine & Pharmacotherapy 2023; 167: 115561 doi: 10.1016/j.biopha.2023.115561
|
| 19 |
Yang Gao, Tong Wang, Wei Zhang, Xiaowei Shi, Shining Ma, Lijuan Wang, Shuai Zhou, Defeng Wang, Meyer Magali, Changqing Guo. Effect of acupotomy on chondrocyte proliferation and expression of CyclinD1, CDK4 and CDK6 in rabbits with knee osteoarthritis. Journal of Traditional Chinese Medical Sciences 2019; 6(3): 277 doi: 10.1016/j.jtcms.2019.08.005
|
| 20 |
Fatemeh Ebadi Meinag, Mina Fatahi, Vahid Vahedian, Nazila Fathi Maroufi, Bashir Mosayyebi, Elham Ahmadi, Mohammad Rahmati. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view. Functional & Integrative Genomics 2024; 24(5) doi: 10.1007/s10142-024-01431-x
|
| 21 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26: 892 doi: 10.1016/j.omtn.2021.10.004
|
| 22 |
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Peixin Dong, Nikolaus Gassler, Mohammad Taheri, Aria Baniahmad, Nader Akbari Dilmaghani. A review on the role of cyclin dependent kinases in cancers. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02747-z
|
| 23 |
Qingyi Hu, Tao Huang. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition. International Journal of Molecular Sciences 2023; 24(10): 8939 doi: 10.3390/ijms24108939
|
| 24 |
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh, Gorka Orive. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today 2022; 27(2): 436 doi: 10.1016/j.drudis.2021.09.020
|
| 25 |
Huize Zhang, Yong Li, Yi Liu. An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1374264
|
| 26 |
Hui Cao, Xiaosong Chen, Zhijun Wang, Lei Wang, Qiang Xia, Wei Zhang. The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation. Cell Death Discovery 2020; 6(1) doi: 10.1038/s41420-020-0287-y
|
| 27 |
Xun Wu, Yi-Shing Lisa Cheng, Mathew Matthen, Angela Yoon, Gary K. Schwartz, Shashi Bala, Alison M. Taylor, Fatemeh Momen-Heravi. Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01865-2
|
| 28 |
Chenyu Liang, Miao Huang, Tianqi Li, Lu Li, Hayley Sussman, Yao Dai, Dietmar W. Siemann, Mingyi Xie, Xin Tang. Towards an integrative understanding of cancer mechanobiology: calcium, YAP, and microRNA under biophysical forces. Soft Matter 2022; 18(6): 1112 doi: 10.1039/D1SM01618K
|
| 29 |
Jia Chen, Qingyun Zhou, Ying Lu. Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.946392
|
| 30 |
Paras Famta, Saurabh Shah, Naitik Jain, Kondasingh Charan Kumar, Deepkumar Bagasariya, Dharmendra Kumar Khatri, Rajeev Singh Raghuvanshi, Shashi Bala Singh, Saurabh Srivastava. Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer. Life Sciences 2022; 310: 121125 doi: 10.1016/j.lfs.2022.121125
|
| 31 |
Dongdong Xue, Jingzhao Han, Ze Liang, Lin Jia, Yifan Liu, Hongfang Tuo, Yanhui Peng. Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 99 doi: 10.2147/JHC.S351038
|
| 32 |
Nan-nan Chen, Ke-fan Zhou, Zhuang Miao, Yun-xia Chen, Jing-xia Cui, Su-wen Su. Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/NOTCH1. Molecular and Cellular Probes 2024; 76: 101964 doi: 10.1016/j.mcp.2024.101964
|
| 33 |
Joanna Szczepanek, Andrzej Tretyn. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications. Biomolecules 2023; 13(11): 1590 doi: 10.3390/biom13111590
|
| 34 |
Yimei Wang, Mei-Juan Tu, Ai-Ming Yu. Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1423416
|